CVS Health Corporation CVS posted adjusted earnings per share (EPS) of $1.19 in the fourth quarter of 2024, down 43.9% year ...

Omnicell, Inc. OMCL reported fourth-quarter 2024 adjusted earnings per share (EPS) of 60 cents, which surged 81.8% year over ...

“Led by robust demand across our Pharmaceutical and Specialty Solutions segment, we are again pleased to raise our fiscal 2025 enterprise guidance.” Cardinal Health raised its FY25 non-GAAP ...

Increased demand for specialty and personalized drugs will drive a portion of increased pharmaceutical spend, according to the report. The high-cost drugs account for 54% of total drug spending ...

DUBLIN, Ohio – Cardinal Health’s acquisition of Advanced Diabetes Supply Group hasn’t closed yet, but company officials said on a conference call to discuss second quarter financial results that ...

Cardinal Health Inc (NYSE:CAH) reported strong second quarter results, driven by robust demand in pharmaceutical and specialty solutions. The company raised its fiscal '25 EPS guidance to a range of ...

specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory ...

U.S. drug distributors are strengthening their position in the specialty ... Group's pharmacy benefit management unit OptumRX in 2024. On an adjusted basis, Cardinal Health reported a profit ...